Analysis of Recurrent Angiotensin Converting Enzyme Inhibitor-Induced Angioedema
- 1 December 2008
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 118 (12), 2115-2120
- https://doi.org/10.1097/mlg.0b013e318182f805
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Are Language Barriers Associated With Serious Medical Events in Hospitalized Pediatric Patients?Pediatrics, 2005
- An evaluation of risk factors for adverse drug events associated with angiotensin‐converting enzyme inhibitorsJournal of Evaluation in Clinical Practice, 2004
- Airway Compromise Due to Angiotensin-Converting Enzyme Inhibitor-Induced AngioedemaChest, 2004
- Angiotensin‐converting enzyme inhibitor related angioedema and the anaesthetistAnaesthesia, 2004
- Vasopeptidase inhibition and angio-oedemaThe Lancet, 2000
- Angioedema due to ACE inhibitors: increased risk in patients of African originBritish Journal of Clinical Pharmacology, 1999
- Predicting airway risk in angioedema: Staging system based on presentationOtolaryngology -- Head and Neck Surgery, 1999
- Recurrent Angiotensin-Converting Enzyme Inhibitor—Associated AngioedemaJAMA, 1997
- Angioedema: 5 Years' experience, with a review of the disorder's presentation and treatmentThe Laryngoscope, 1992
- Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.BMJ, 1988